RARE — Ultragenyx Pharmaceutical Inc.

Exchange: NASDAQ • IR Tier: D

Subscribe to RARE Earnings Calendar

http://earningstracker.com/cal/RARE.ics Add to Google Calendar

Sentiment Analysis

Analyzer Overall Avg Score Avg Confidence Positive Neutral Negative Reports
finbert-finbert positive 0.61 73% 18 6 0 24
vader positive 1.00 67% 24 0 0 24

Earnings History

Period Date Timing Status Call Time (ET) EPS Revenue Sentiment
Q4 2025 2026-02-12 CONFIRMED 1.29 $673 million POSITIVE
Q3 2025 2025-11-04 CONFIRMED 1.81 $160 million POSITIVE
Q2 2025 2025-08-05 CONFIRMED 1.17 $166 million POSITIVE
Q1 2025 2025-05-06 CONFIRMED 1.57 $139 million POSITIVE
Q4 2024 2025-02-13 CONFIRMED 1.39 $560 million NEUTRAL